Parvovirus B19 infection in children with acute illness and rash

Pediatric Dermatology

Volumn 23, Issue 3, 2006, Pages 216-218

  Pruksachatkunakorn, Chulabhorn ^a   Apichartpiyakul, Nisarat ^a   Kanjanaratanakorn, Kittika ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ACUTE DISEASE; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; INFANT; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARVOVIRUS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; SAMPLE; TIME SERIES ANALYSIS; UNIVERSITY HOSPITAL; URTICARIA; VIRUS INFECTION;

ACUTE DISEASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; EXANTHEMA; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREVALENCE; PROSPECTIVE STUDIES; SEROLOGIC TESTS; THAILAND;

EID: 33745082404     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2006.00220.x     Document Type: Article

References (20)

1. Cherry JD. Parvovirus infections in children and adults. Adv Pediatr 1999 46: 245 269.
2. Shirley JA Revill S Cohen BJ et al. Serological study of rubella-like illnesses. J Med Virol 1987 21: 369 379.
3. Boeck K Mempel M Schmidt T et al. Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children. Cutis 1998 62: 271 274.
4. Holm JM Hansen LK Oxhøj H. Kawasaki disease associated with parvovirus B19 infection. Eur J Pediatr 1995 154: 633 634.
5. Watanabe T Oda Y. Henoch-Schönlein purpura nephritis associated with human parvovirus B19 infection. Pediatr Int 2000 42: 94 96.
6. Petter G Rytter M Haustein UF. Juvenile papular-purpuric gloves and socks syndrome. J Eur Acad Dermatol Venereol 2001 15: 340 342.
7. Alfadley A Aljubran A Hainau B et al. Papular-purpuric "gloves and socks" syndrome in a mother and daughter. J Am Acad Dermatol 2003 48: 941 944.
8. Garcia-Tapia AM Fernandez-Gutierrez del Alamo C Giron JA et al. Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain. Clin Infect Dis 1995 21: 1424 1430.
9. Trapani S Ermini M Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum 1999 28: 319 325.
10. Magro CM Dawood MR Crowson AN. The cutaneous manifestations of human parvovirus B19 infection. Hum Pathol 2000 31: 488 497.
11. Poovorawan Y Theamboonlers A Suandork P et al. Prevalence of antibodies to parvovirus B19 in Thailand. Southeast Asian J Trop Med Public Health 2000 31: 422 424.
12. Koch WC. Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr Opin Infect Dis 2001 14: 343 356.
13. Meyer O. Parvovirus B19 and autoimmune diseases. Joint Bone Spine 2003 70: 6 11.
14. Young NS Brown KE. Parvovirus B19. N Engl J Med 2004 350: 586 597.
15. Anderson LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987 6: 711 718.
16. Anderson LJ. Human parvoviruses. J Infect Dis 1990 161: 603 608.
17. Whitton JL Oldstone MBA. Immune response to viruses. In: Knipe DM Howley PM Griffin DE et al eds. Fields virology, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 285 320.
18. Lim WL Wong KF Lau CS. Parvovirus B19 infection in Hong Kong. J Infect 1997 35: 247 249.
19. Nigro G Zerbini M Krzysztofiak A et al. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet 1994 343: 1260 1261.
20. Matsunaga Y Goh KT Utagawa E et al. Low prevalence of antibody to human parvovirus B19 in Singapore. Epidemiol Infect 1994 113: 537 540.